Kimberly-Clark to acquire Tylenol's parent company Kenvue in record-breaking $48.7 billion deal

Kimberly-Clark to acquire Tylenol's parent company Kenvue in a $48.7 billion mega-deal, creating a massive consumer products conglomerate, marking the latest major merger in the industry. The deal will unite two well-established brands under one umbrella, further expanding the reach of both companies' products. The acquisition is expected to solidify Kimberly-Clark's position as a leading player in the global consumer goods market. The merged entity will operate under a new name and be headquartered in Chicago.